Publication
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)
Journal Paper/Review - Jan 4, 2021
Urwyler Pascal, Sendi Parham, Albrich Werner, Stüssi-Helbling Melina, Huber Lars C, Bacci Marcelo R, Camacho-Ortiz Adrián, Sumer Johannes, Thoma Reto, Trendelenburg Marten, Heijnen Ingmar A F M, Moser Stephan, Charitos Panteleimon, Osthoff Michael
Urwyler, Pascal
1
0
Charitos, Panteleimon
1
0
Moser, Stephan
1
0
Heijnen, Ingmar A F M
2
0
Trendelenburg, Marten
6
0
Thoma, Reto
5
0
Sumer, Johannes
Division of Infectious Diseases, Infection Prevention and Travel Medicine · Dept. I
9
0
Camacho-Ortiz, Adrián
1
0
Bacci, Marcelo R
1
0
Huber, Lars C
3
0
Stüssi-Helbling, Melina
1
0
Albrich, Werner
chief of serviceDivision of Infectious Diseases, Infection Prevention and Travel Medicine · Dept. I
107
12
Sendi, Parham
6
0
Osthoff, Michael
7
0